University of Maryland, Baltimore Grants Spherix Exclusive Option to License Anthrax Based Ovarian Cancer Drug PrAg-PAS
NEW YORK, Sept. 17, 2019 /PRNewswire/ — Spherix Incorporated (Nasdaq: SPEX) today announced that the Company…
NEW YORK, Sept. 17, 2019 /PRNewswire/ — Spherix Incorporated (Nasdaq: SPEX) today announced that the Company…
CHICAGO, Sept. 17, 2019 /PRNewswire/ — The Chartis Group, a leading provider of comprehensive advisory…
SEATTLE and COLUMBIA, Md., Sept. 17, 2019 /PRNewswire/ — Welldoc, a leader in digital health,…
LONDON, Sept. 17, 2019 /PRNewswire/ — Senzer Pharmaceuticals has been granted a CE Mark that certifies…
MELVILLE, N.Y., Sept. 17, 2019 /PRNewswire/ — Expanding the company’s lineup of eye-care product offerings, Canon…
PHILADELPHIA, Sept. 17, 2019 /PRNewswire/ — The Pew Charitable Trusts announced today the six pairs of…
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — MedCrypt Inc., the proactive healthcare security provider, today announced…
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — LunaPBC — founder of LunaDNA, the first community-owned genomic…
LAS VEGAS, Sept. 17, 2019 /PRNewswire/ — Conduit Health Partners, a patient access company that develops…
WHITEHOUSE STATION, N.J., Sept. 17, 2019 /PRNewswire/ — A new study from Chubb finds that when…